Soleno Therapeutics, Inc. (SLNO)
SLNO moved a median of 0.00% 30 minutes after news, and +0.01% by the close. How SLNO actually reacts to news — the realized, point-in-time move the market made, measured across 1,089 labeled events over the last three years with zero look-ahead.
SLNO’s median reaction, across the day.
| Horizon | Median | % positive | Events |
|---|---|---|---|
| 5-min | 0.00% | 46% | 990 |
| 30-min | 0.00% | 49% | 995 |
| 60-min | 0.00% | 49% | 995 |
| to close | +0.01% | 51% | 987 |
| Middle 50% of SLNO reactions | -0.65% to +0.69% |
|---|---|
| Median reaction (30-min) | 0.00% |
| Measured reactions | 1,089 |
Half of all Soleno Therapeutics, Inc. news events land between -0.65% and +0.69% at 30 minutes.
Reaction stats as of 2026-09-21. Newest measured event . Reaction = percent move vs. the price at the news timestamp.
How SLNO reacts, by analyst action.
| Event | Events | Median 30-min | % positive | Median to close |
|---|---|---|---|---|
| Analyst downgrades | 22 | -0.02% | 36% | +0.17% |
| Coverage initiations | 25 | -0.89% | 20% | +0.68% |
| Rating reiterations | 57 | +0.04% | 51% | +0.10% |
| Price-target raises | 17 | -0.43% | 35% | -0.25% |
Last 3 years, pulled 2026-09-21. Reaction = percent move vs. the price at the news timestamp. Counts and medians only. The same measurement runs across every name in the dataset. 2 further classes were observed with fewer than 10 measured events and are not published. See how SLNO ranks against every other measured name →
That’s how SLNO usually reacts — get an email when it moves on news →Email me when SLNO moves on news.
One email per qualifying move — the headline, the measured reaction, and how it compares to SLNO's baseline. Nothing else.
Recent SLNO events, each with its measured reaction.
| Date | Headline | Event | Source | 5-min | To close |
|---|---|---|---|---|---|
| Bronstein, Gewirtz & Grossman, LLC Is Investigating Soleno Therapeutics, Inc. (SLNO) And Encourages Stockholders to Connect | Press release | ACCESS Newswire | — | — | |
| Soleno Therapeutics, Inc. (SLNO) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation | Press release | ACCESS Newswire | — | — | |
| Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Soleno Therapeutics, Inc. (SLNO) and Encourages Stockholders to Learn More About the Investigation | Press release | ACCESS Newswire | — | — | |
| Bronstein, Gewirtz & Grossman, LLC Encourages Soleno Therapeutics, Inc. (SLNO) Investors to Inquire about Securities Investigation | Press release | ACCESS Newswire | — | — | |
| Bronstein, Gewirtz & Grossman, LLC Is Investigating Soleno Therapeutics, Inc. (SLNO) And Encourages Shareholders to Connect | Press release | ACCESS Newswire | — | — | |
| Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Soleno Therapeutics, Inc. (SLNO) and Encourages Shareholders to Learn More About the Investigation | Press release | ACCESS Newswire | — | — | |
| Soleno Therapeutics, Inc. (SLNO) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation | Press release | ACCESS Newswire | — | — | |
| Bronstein, Gewirtz & Grossman, LLC Is Investigating Soleno Therapeutics, Inc. (SLNO) And Encourages Stockholders to Connect | Press release | ACCESS Newswire | — | — | |
| Soleno Therapeutics, Inc. (SLNO) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation | Press release | ACCESS Newswire | — | — | |
| Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Soleno Therapeutics, Inc. (SLNO) and Encourages Stockholders to Learn More About the Investigation | Press release | ACCESS Newswire | — | — | |
| Bronstein, Gewirtz & Grossman, LLC Encourages Soleno Therapeutics, Inc. (SLNO) Investors to Inquire about Securities Investigation | Press release | ACCESS Newswire | — | — | |
| Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Soleno Therapeutics, Inc. (SLNO) and Encourages Shareholders to Learn More About the Investigation | Press release | ACCESS Newswire | — | — | |
| Bronstein, Gewirtz & Grossman, LLC Encourages Soleno Therapeutics, Inc. (SLNO) Shareholders to Inquire about Securities Investigation | Press release | ACCESS Newswire | — | — | |
| Bronstein, Gewirtz & Grossman, LLC Is Investigating Soleno Therapeutics, Inc. (SLNO) And Encourages Shareholders to Connect | Press release | ACCESS Newswire | — | — | |
| Bronstein, Gewirtz & Grossman, LLC Encourages Soleno Therapeutics, Inc. (SLNO) Stockholders to Inquire about Securities Investigation | Press release | ACCESS Newswire | — | — | |
| Soleno Therapeutics, Inc. (SLNO) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation | Press release | ACCESS Newswire | — | — | |
| Bronstein, Gewirtz & Grossman, LLC Encourages Soleno Therapeutics, Inc. (SLNO) Stockholders to Inquire about Securities Investigation | Press release | ACCESS Newswire | — | — | |
| Soleno Therapeutics, Inc. (SLNO) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation | Press release | ACCESS Newswire | — | — | |
| Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Soleno Therapeutics, Inc. (SLNO) and Encourages Stockholders to Learn More About the Investigation | Press release | ACCESS Newswire | — | — | |
| Bronstein, Gewirtz & Grossman, LLC Encourages Soleno Therapeutics, Inc. (SLNO) Investors to Inquire about Securities Investigation | Press release | ACCESS Newswire | — | — | |
| Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Soleno Therapeutics, Inc. (SLNO) And Encourages Stockholders to Reach Out | Press release | ACCESS Newswire | — | — | |
| Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Soleno Therapeutics, Inc. (SLNO) and Encourages Shareholders to Learn More About the Investigation | Press release | ACCESS Newswire | — | — | |
| Bronstein, Gewirtz & Grossman, LLC Encourages Soleno Therapeutics, Inc. (SLNO) Shareholders to Inquire about Securities Investigation | Press release | ACCESS Newswire | — | — | |
| Bronstein, Gewirtz & Grossman, LLC Is Investigating Soleno Therapeutics, Inc. (SLNO) And Encourages Shareholders to Connect | Press release | ACCESS Newswire | — | — | |
| Bronstein, Gewirtz & Grossman, LLC Encourages Soleno Therapeutics, Inc. (SLNO) Stockholders to Inquire about Securities Investigation | Press release | ACCESS Newswire | — | — | |
| Soleno Therapeutics, Inc. (SLNO) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation | Press release | ACCESS Newswire | — | — | |
| Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Soleno Therapeutics, Inc. (SLNO) and Encourages Stockholders to Learn More About the Investigation | Press release | ACCESS Newswire | — | — | |
| Bronstein, Gewirtz & Grossman, LLC Encourages Soleno Therapeutics, Inc. (SLNO) Investors to Inquire about Securities Investigation | Press release | ACCESS Newswire | — | — | |
| Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Soleno Therapeutics, Inc. (SLNO) And Encourages Stockholders to Reach Out | Press release | ACCESS Newswire | — | — | |
| Bronstein, Gewirtz & Grossman, LLC Is Investigating Soleno Therapeutics, Inc. (SLNO) And Encourages Stockholders to Connect | Press release | ACCESS Newswire | — | — | |
| Bronstein, Gewirtz & Grossman, LLC Encourages Soleno Therapeutics, Inc. (SLNO) Shareholders to Inquire about Securities Investigation | Press release | ACCESS Newswire | — | — | |
| Bronstein, Gewirtz & Grossman, LLC Is Investigating Soleno Therapeutics, Inc. (SLNO) And Encourages Shareholders to Connect | Press release | ACCESS Newswire | — | — | |
| Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Soleno Therapeutics, Inc. (SLNO) And Encourages Shareholders to Reach Out | Press release | ACCESS Newswire | — | — | |
| Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Soleno Therapeutics, Inc. (SLNO) and Encourages Shareholders to Learn More About the Investigation | Press release | ACCESS Newswire | — | — | |
| Soleno Therapeutics, Inc. (SLNO) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation | Press release | ACCESS Newswire | — | — | |
| Bronstein, Gewirtz & Grossman, LLC Encourages Soleno Therapeutics, Inc. (SLNO) Stockholders to Inquire about Securities Investigation | Press release | ACCESS Newswire | — | — | |
| Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Soleno Therapeutics, Inc. (SLNO) And Encourages Stockholders to Reach Out | Press release | ACCESS Newswire | — | — | |
| Form 15-12G SOLENO THERAPEUTICS INC | SEC filing · Form 15-12G | SEC EDGAR | — | — | |
| Form EFFECT SOLENO THERAPEUTICS INC | SEC filing · Form EFFECT | SEC EDGAR | — | — | |
| Bronstein, Gewirtz & Grossman, LLC Is Investigating Soleno Therapeutics, Inc. (SLNO) And Encourages Stockholders to Connect | Press release | ACCESS Newswire | — | — | |
| Soleno Therapeutics, Inc. (SLNO) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation | Press release | ACCESS Newswire | — | — | |
| Form AW SOLENO THERAPEUTICS INC | SEC filing · Form AW | SEC EDGAR | — | — | |
| Form POS AM SOLENO THERAPEUTICS INC | SEC filing · Form POS | SEC EDGAR | — | — | |
| Form 8-K SOLENO THERAPEUTICS INC For: May 18 | SEC filing · Form 8-K | SEC EDGAR | — | — | |
| Form POSASR SOLENO THERAPEUTICS INC | SEC filing · Form POSASR | SEC EDGAR | — | — | |
| Form S-8 POS SOLENO THERAPEUTICS INC | SEC filing · Form S-8 | SEC EDGAR | — | — | |
| Are SEM, XOMA, SLNO, KORE Obtaining Fair Deals for their Shareholders? | Press release | PR Newswire | -0.04% | -0.04% | |
| Form 10-Q SOLENO THERAPEUTICS INC For: Mar 31 | SEC filing · Form 10-Q | SEC EDGAR | +0.01% | +0.00% | |
| Halper Sadeh LLC is Investigating Whether SLNO, APLS, HLX are Obtaining Fair Deals for their Shareholders | Press release | GlobeNewswire | +0.01% | +0.03% | |
| Soleno Therapeutics, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - SLNO | Press release | PR Newswire | +0.02% | +0.10% |
Each reaction is the move the market actually made, measured from the news timestamp. Headlines link through to the SLNO section they belong to.
Where else SLNO is measured.
SLNO earnings → · Analyst actions → · SEC filings →
Other Healthcare names, measured the same way
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| CVS Health Corporation (CVS) | 1,095 | +0.02% | 51% |
| Idera Pharmaceuticals, Inc. (IDRA) | 1,094 | -0.27% | 42% |
| Zogenix, Inc. (ZGNX) | 1,086 | -0.08% | 45% |
| Reata Pharmaceuticals, Inc. - Class A (RETA) | 1,073 | +0.07% | 52% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not.
All Healthcare names, measured the same way →
Every ticker we measure the same way24
Apple (AAPL)
How AAPL actually reacts to news, measured.
NVIDIA (NVDA)
How NVDA actually reacts to news, measured.
Tesla (TSLA)
How TSLA actually reacts to news, measured.
Microsoft (MSFT)
How MSFT actually reacts to news, measured.
Advanced Micro Devices (AMD)
How AMD actually reacts to news, measured.
Amazon (AMZN)
How AMZN actually reacts to news, measured.
Alphabet (GOOG)
How GOOG actually reacts to news, measured.
Meta Platforms (META)
How META actually reacts to news, measured.
Broadcom (AVGO)
How AVGO actually reacts to news, measured.
JPMorgan Chase (JPM)
How JPM actually reacts to news, measured.
Visa (V)
How V actually reacts to news, measured.
Walmart (WMT)
How WMT actually reacts to news, measured.
Eli Lilly (LLY)
How LLY actually reacts to news, measured.
UnitedHealth Group (UNH)
How UNH actually reacts to news, measured.
Netflix (NFLX)
How NFLX actually reacts to news, measured.
Johnson & Johnson (JNJ)
How JNJ actually reacts to news, measured.
Exxon Mobil (XOM)
How XOM actually reacts to news, measured.
Home Depot (HD)
How HD actually reacts to news, measured.
Costco (COST)
How COST actually reacts to news, measured.
Mastercard (MA)
How MA actually reacts to news, measured.
Oracle (ORCL)
How ORCL actually reacts to news, measured.
Salesforce (CRM)
How CRM actually reacts to news, measured.
Bank of America (BAC)
How BAC actually reacts to news, measured.
Coca-Cola (KO)
How KO actually reacts to news, measured.
Walt Disney (DIS)
How DIS actually reacts to news, measured.
Browse all tickers
Every name we’ve measured, in one place.
How the numbers are made.
How is Soleno Therapeutics, Inc.'s median reaction calculated?
Every labeled SLNO news event is measured from its own timestamp: the last trade before the news is the base price, and the move is read at fixed horizons — 30 minutes of trading, then the close. The median across 1,089 events is what this page reports. Point-in-time, zero look-ahead: no event borrows information from a later one.
What counts as a positive reaction?
Any event whose price move is above zero at the horizon, relative to the last trade before the news timestamp. 49% of SLNO's measured events are up at 30 minutes; the rest close the window flat or negative.
How often is this page updated?
The news table refreshes automatically as new events are labeled and priced. The reaction medians are re-pulled in batches from the dataset — the figures here are as of 2026-09-21.
Does SLNO's past reaction predict its next one?
No. These are realized facts about past events, not forecasts. They describe a distribution — they say nothing certain about any future move.